In an advance for HIV vaccine research, a scientific team has discovered how the immune system makes a powerful antibody that blocks HIV infection of cells by targeting a site on the virus called V1V2. Many researchers believe that if a vaccine elicited potent antibodies to a specific conserved site in the V1V2 region, one of a handful of sites that remains constant on the fast-mutating virus, then the vaccine could protect people from HIV infection. The new findings point the way toward a vaccine that would generate such antibodies. Learn more about this advance. |
Workforce and Patient Safety. April 24, 2024
Hace 10 horas
No hay comentarios:
Publicar un comentario